Parietex TET5050Recalls & reported problems
Sofradim Production · Hydrophilic 3-Dimensional Mesh,Polyester · Class 2 · Implant
All models of Parietex (73)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 6
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 10884521180369), received between Nov 7, 2017 and Aug 29, 2022 — classified as 6 injuries.
The most frequently reported specific device problem is “Patient Device Interaction Problem” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem6
- Patient Device Interaction Problem3
- Migration or Expulsion of Device2
- Degraded1
- Material Split, Cut or Torn1
Patient problems
- Adhesion(s)6
- Hernia6
- Unspecified Tissue Injury6
- Pain5
- Unspecified Infection5
- Abscess4
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available4
- Ascites3
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
InjuryAug 29, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE PATIENT¿S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. THE PRODUCT WAS USED FOR THERAPEUTIC TREATMENT OF A VENTRAL INCISIONAL HERNIA. IT WAS REPORTED THAT AFTER IMPLANT, THE PATIENT EXPERIENCED EXTENSIVE ADHESIONS, RECURRENT INCISIONAL HERNIA, SEROMA, SEROSAL TEAR OF BOWEL, AND INFLAMMATION. POST-OPERATIVE PATIENT TREATMENT INCLUDED REVISION SURGERY, ADHESIOLYSIS, AND DRAINING.
Patient problems: Adhesion(s); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Hernia; Inflammation; Seroma; Unspecified Tissue Injury
MAUDE report 15312588 ↗InjuryJun 2, 2022Adverse Event Without Identified Device or Use Problem; Patient Device Interaction Problem; Adverse Event Without Identified Device or Use Problem; Patient Device Interaction Problem
THE PATIENT¿S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. THE PRODUCT WAS USED FOR THERAPEUTIC TREATMENT OF A HERNIA. IT WAS REPORTED THAT AFTER THE IMPLANT, THE PATIENT EXPERIENCED INFECTION AND ABSCESS. POST-OPERATIVE PATIENT TREATMENT INCLUDED EXCISIONAL DEBRIDEMENT OF ABDOMEN AND EVACUATION OF ASSOCIATED ABSCESS COMPLEX, EXCISION OF INFECTED TISSUE AND PARTIAL EXCISION OF MESH.
Patient problems: Abscess; Adhesion(s); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Ascites; Bacterial Infection; Chills; Discomfort; Erythema; Fever; Fluid Discharge; Hernia; Impaired Healing; Nausea; Necrosis; Pain; Purulent Discharge; Scar Tissue; Unspecified Infection; Unspecified Tissue Injury
MAUDE report 14578633 ↗InjuryMay 28, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE PATIENT¿S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. THE PRODUCT WAS USED FOR THERAPEUTIC TREATMENT OF A INCISIONAL HERNIA, AND A PARASTOMAL HERNIA. IT WAS REPORTED THAT AFTER IMPLANT, THE PATIENT EXPERIENCED FISTULA, INFECTION, ABSCESS, PAIN, HERNIA RECURRENCE, ADHESIONS, LIMITATIONS ON PHYSICAL ACTIVITY, AND EMOTIONAL INJURIES WITHOUT TREATMENT. POST-OPERATIVE PATIENT TREATMENT INCLUDED REVISION SURGERY, BOWEL RESECTION, TRANSFERRED TO BARIATRIC BED AND TAKEN DIRECTLY TO ICU, INTUBATED/VENTILATED, AND WOUND VAC.
Patient problems: Abscess; Adhesion(s); Emotional Changes; Fistula; Hernia; Pain; Unspecified Infection; Unspecified Tissue Injury
MAUDE report 11900529 ↗InjuryNov 8, 2019Adverse Event Without Identified Device or Use Problem; Patient Device Interaction Problem; Adverse Event Without Identified Device or Use Problem; Patient Device Interaction Problem
THE PATIENT¿S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. THE PRODUCT WAS USED FOR THERAPEUTIC TREATMENT OF A HERNIA. IT WAS REPORTED THAT AFTER IMPLANT, THE PATIENT EXPERIENCED INFECTION, OPEN DRAINING WOUND, FLUID COLLECTION, LEUKOCYTOSIS, MRSA, ABSCESS, LEG SWELLING, RASH ON LEFT LEG, FEVER, ABDOMINAL PAIN, MALAISE, PAIN, LEUKOCLASTIC VASCULITIS, ERYTHEMA, ADHESIONS. POST-OPERATIVE PATIENT TREATMENT INCLUDED REVISION SURGERIES, CT SCAN, WOUND VAC, ANTIBIOTICS, HOSPITALIZATION, IV ANTIBIOTICS, IRRIGATION OF FLUID COLLECTION, PAIN MEDICATION, PICC LINE PLACEMENT, WOUND EXPLORATION, DRAIN PLACEMENT, SINOGRAM.
Patient problems: Abdominal Pain; Abscess; Adhesion(s); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Ascites; Bacterial Infection; Erythema; Fever; Fluid Discharge; Hernia; Impaired Healing; Injury; Malaise; Pain; Perforation; Rash; Scar Tissue; Swelling/ Edema; Unspecified Infection; Unspecified Tissue Injury
MAUDE report 9294411 ↗InjuryMar 3, 2018Degraded; Migration or Expulsion of Device; Adverse Event Without Identified Device or Use Problem; Patient Device Interaction Problem; Material Split, Cut or Torn; Degraded; Migration or Expulsion of Device; Adverse Event Without Identified Device or Use Problem; Patient Device Interaction Problem; Material Split, Cut or Torn
THE PATIENT'S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE RESULTING IN AN UNSPECIFIED ADVERSE OUTCOME. PRODUCT WAS USED FOR THERAPEUTIC TREATMENT. THE PATIENT HAS EXPERIENCED REMOVALS, INFECTION, AND FISTULA.
Patient problems: Abdominal Pain; Adhesion(s); Anemia; Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Ascites; Dehydration; Dizziness; Edema; Erythema; Fever; Fistula; Fluid Discharge; Headache; Hematoma; Hemorrhage/Blood Loss/Bleeding; Hernia; Impaired Healing; Inflammation; Injury; Loss of consciousness; Muscle Weakness/Atrophy; Necrosis; No Code Available; Obstruction/Occlusion; Pain; Pallor; Pneumonia; Purulent Discharge; Renal Failure; Scar Tissue; Sepsis; Seroma; Sleep Dysfunction; Swelling/ Edema; Tachycardia; Thrombosis/Thrombus; Ulcer; Unspecified Infection; Unspecified Tissue Injury; Urinary Retention; Urinary Tract Infection
MAUDE report 7311990 ↗InjuryNov 7, 2017Migration or Expulsion of Device; Adverse Event Without Identified Device or Use Problem; Migration or Expulsion of Device; Adverse Event Without Identified Device or Use Problem
THE PATIENT¿S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. THE PRODUCT WAS USED FOR THERAPEUTIC TREATMENT OF A VENTRAL HERNIA. IT WAS REPORTED THAT AFTER THE IMPLANT, THE PATIENT EXPERIENCED ADHESIONS, INFECTION, ABSCESS, CHRONIC PAIN AND MESH MIGRATION. POST-OPERATIVE PATIENT TREATMENT INCLUDED REVISION SURGERY AND MESH REMOVAL.
Patient problems: Abscess; Adhesion(s); Hernia; Hypersensitivity/Allergic reaction; Inflammation; No Code Available; Pain; Seroma; Unspecified Infection; Unspecified Tissue Injury
MAUDE report 7007142 ↗
Other Mesh, surgical, polymeric devices
- PROCEED PVPMJohnson & Johnson International Inc. · Mesh, surgical, polymeric1,233 reports
- PROCEED PCDN1Johnson & Johnson International Inc. · Mesh, surgical, polymeric744 reports
- PROCEED PCDG1Johnson & Johnson International Inc. · Mesh, surgical, polymeric1 recall1 death637 reports
- PROCEED PVPSJohnson & Johnson International Inc. · Mesh, surgical, polymeric622 reports
- ProGrip LPG1510Sofradim Production · Mesh, surgical, polymeric2 deaths616 reports
- VENTRALEX 0010302Davol Inc. · Mesh, surgical, polymeric4 deaths531 reports
- BARD 0112680Davol Inc. · Mesh, surgical, polymeric1 death494 reports
- ProGrip TEM1509GSofradim Production · Mesh, surgical, polymeric3 deaths471 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page